Steven Rosenzweig to Receptor, IGF Type 1
This is a "connection" page, showing publications Steven Rosenzweig has written about Receptor, IGF Type 1.
Connection Strength
1.458
-
Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem Pharmacol. 2010 Oct 15; 80(8):1115-24.
Score: 0.359
-
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. Cancer Lett. 2007 Apr 18; 248(2):269-79.
Score: 0.276
-
Paradoxical effects of the phage display-derived peptide antagonist IGF-F1-1 on insulin-like growth factor-1 receptor signaling. Biochem Pharmacol. 2006 Jun 28; 72(1):53-61.
Score: 0.268
-
The Continuing Evolution of Insulin-like Growth Factor Signaling. F1000Res. 2020; 9.
Score: 0.176
-
Insulin like growth factor 1 receptor signal transduction to the nucleus. Adv Exp Med Biol. 1993; 343:159-68.
Score: 0.107
-
Acquired resistance to drugs targeting receptor tyrosine kinases. Biochem Pharmacol. 2012 Apr 15; 83(8):1041-8.
Score: 0.100
-
IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 14; 342(3):851-8.
Score: 0.066
-
Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface. Biochemistry. 2004 Sep 14; 43(36):11533-45.
Score: 0.060
-
Synthesis and characterization of insulin-like growth factor (IGF)-1 photoprobes selective for the IGF-binding proteins (IGFBPS). photoaffinity labeling of the IGF-binding domain on IGFBP-2. J Biol Chem. 2001 Jan 26; 276(4):2880-9.
Score: 0.046